Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | District of Columbia |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Sep 25, 2025 |
| Due Date: | Sep 30, 2025 |
| Solicitation No: | ARPA-H-SN-25-131 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Sep 25, 2025 09:02 am EDT
- Original Response Date: Sep 30, 2025 11:59 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Oct 15, 2025
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
Washington , DC 20005USA
This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers’ Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122).
For additional PD details and registration information see the attached special notice (ARPA-H-SN-25-131).
For more information about the THRIVE program visit: https://arpa-h.gov/explore-funding/programs/thrive
- 1301 K Street NW Suite 1200 West
- Washington , DC 20005
- USA
- THRIVE Program
- THRIVE@arpa-h.gov
- Sep 25, 2025 09:15 am EDT Solicitation (Original)
- Sep 25, 2025 09:02 am EDTSpecial Notice (Original)
Related Document
| Oct 1, 2025 | [Special Notice (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) |
See Also
Follow Strategic Capabilities Office Broad Agency Announcement Active Contract Opportunity Notice ID HQ0034-SCO-24-BAA-0001
Federal Agency
Due by 1/16/2029
Follow NEEDIPEDIA BROAD AGENCY ANNOUNCEMENT - BAA Active Contract Opportunity Notice ID HHM402-23-S-0001
Federal Agency
Due by 12/26/2028
Follow ARPA-H Emerging Health Innovators (EHI) Initiative Active Contract Opportunity Notice ID ARPA-H-SOL-26-150
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 2/10/2027
Follow IARPA Solutions Marketplace Active Contract Opportunity Notice ID IARPA-OT-26-001 Related Notice Department/Ind.
OFFICE OF THE DIRECTOR OF NATIONAL INTELLIGENCE
Due by 7/31/2027